Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 3 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 12 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 14 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 19 |
NetGPI | no | yes: 0, no: 19 |
Related structures:
AlphaFold database: E9AED5
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 20 |
GO:0008289 | lipid binding | 2 | 20 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 24 | 26 | PF00675 | 0.450 |
CLV_PCSK_KEX2_1 | 275 | 277 | PF00082 | 0.767 |
CLV_PCSK_PC1ET2_1 | 275 | 277 | PF00082 | 0.767 |
CLV_PCSK_SKI1_1 | 15 | 19 | PF00082 | 0.355 |
CLV_PCSK_SKI1_1 | 162 | 166 | PF00082 | 0.310 |
CLV_PCSK_SKI1_1 | 171 | 175 | PF00082 | 0.288 |
CLV_PCSK_SKI1_1 | 207 | 211 | PF00082 | 0.394 |
CLV_PCSK_SKI1_1 | 237 | 241 | PF00082 | 0.376 |
CLV_PCSK_SKI1_1 | 334 | 338 | PF00082 | 0.480 |
CLV_PCSK_SKI1_1 | 68 | 72 | PF00082 | 0.353 |
DEG_APCC_DBOX_1 | 14 | 22 | PF00400 | 0.421 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.632 |
DEG_SIAH_1 | 302 | 310 | PF03145 | 0.533 |
DOC_MAPK_gen_1 | 12 | 21 | PF00069 | 0.455 |
DOC_MAPK_gen_1 | 25 | 32 | PF00069 | 0.345 |
DOC_PP4_FxxP_1 | 117 | 120 | PF00568 | 0.295 |
DOC_USP7_MATH_1 | 189 | 193 | PF00917 | 0.253 |
DOC_USP7_MATH_1 | 268 | 272 | PF00917 | 0.706 |
DOC_USP7_MATH_1 | 31 | 35 | PF00917 | 0.416 |
DOC_USP7_UBL2_3 | 215 | 219 | PF12436 | 0.361 |
DOC_USP7_UBL2_3 | 48 | 52 | PF12436 | 0.254 |
DOC_WW_Pin1_4 | 242 | 247 | PF00397 | 0.417 |
DOC_WW_Pin1_4 | 291 | 296 | PF00397 | 0.598 |
LIG_14-3-3_CanoR_1 | 311 | 318 | PF00244 | 0.639 |
LIG_14-3-3_CanoR_1 | 360 | 365 | PF00244 | 0.482 |
LIG_14-3-3_CanoR_1 | 88 | 92 | PF00244 | 0.362 |
LIG_Actin_WH2_2 | 325 | 340 | PF00022 | 0.549 |
LIG_EH1_1 | 309 | 317 | PF00400 | 0.503 |
LIG_eIF4E_1 | 310 | 316 | PF01652 | 0.623 |
LIG_FHA_1 | 177 | 183 | PF00498 | 0.398 |
LIG_FHA_1 | 311 | 317 | PF00498 | 0.557 |
LIG_FHA_1 | 91 | 97 | PF00498 | 0.339 |
LIG_FHA_2 | 342 | 348 | PF00498 | 0.502 |
LIG_FHA_2 | 360 | 366 | PF00498 | 0.533 |
LIG_HCF-1_HBM_1 | 231 | 234 | PF13415 | 0.388 |
LIG_LIR_Apic_2 | 166 | 172 | PF02991 | 0.366 |
LIG_LIR_Apic_2 | 242 | 246 | PF02991 | 0.359 |
LIG_LIR_Gen_1 | 125 | 133 | PF02991 | 0.294 |
LIG_LIR_Gen_1 | 139 | 148 | PF02991 | 0.305 |
LIG_LIR_Gen_1 | 14 | 24 | PF02991 | 0.423 |
LIG_LIR_Gen_1 | 97 | 104 | PF02991 | 0.297 |
LIG_LIR_Nem_3 | 109 | 115 | PF02991 | 0.252 |
LIG_LIR_Nem_3 | 131 | 135 | PF02991 | 0.302 |
LIG_LIR_Nem_3 | 139 | 143 | PF02991 | 0.312 |
LIG_LIR_Nem_3 | 217 | 223 | PF02991 | 0.383 |
LIG_LIR_Nem_3 | 97 | 102 | PF02991 | 0.342 |
LIG_MYND_1 | 246 | 250 | PF01753 | 0.494 |
LIG_PDZ_Class_2 | 361 | 366 | PF00595 | 0.617 |
LIG_Pex14_1 | 243 | 247 | PF04695 | 0.393 |
LIG_Pex14_1 | 38 | 42 | PF04695 | 0.279 |
LIG_PTB_Apo_2 | 120 | 127 | PF02174 | 0.298 |
LIG_PTB_Apo_2 | 134 | 141 | PF02174 | 0.301 |
LIG_PTB_Phospho_1 | 134 | 140 | PF10480 | 0.412 |
LIG_SH2_CRK | 321 | 325 | PF00017 | 0.432 |
LIG_SH2_CRK | 79 | 83 | PF00017 | 0.299 |
LIG_SH2_CRK | 99 | 103 | PF00017 | 0.339 |
LIG_SH2_NCK_1 | 99 | 103 | PF00017 | 0.295 |
LIG_SH2_PTP2 | 169 | 172 | PF00017 | 0.366 |
LIG_SH2_SRC | 247 | 250 | PF00017 | 0.497 |
LIG_SH2_STAP1 | 113 | 117 | PF00017 | 0.295 |
LIG_SH2_STAP1 | 216 | 220 | PF00017 | 0.474 |
LIG_SH2_STAP1 | 42 | 46 | PF00017 | 0.379 |
LIG_SH2_STAT5 | 140 | 143 | PF00017 | 0.391 |
LIG_SH2_STAT5 | 169 | 172 | PF00017 | 0.273 |
LIG_SH2_STAT5 | 183 | 186 | PF00017 | 0.259 |
LIG_SH2_STAT5 | 223 | 226 | PF00017 | 0.414 |
LIG_SH2_STAT5 | 247 | 250 | PF00017 | 0.486 |
LIG_SH2_STAT5 | 348 | 351 | PF00017 | 0.442 |
LIG_SH2_STAT5 | 8 | 11 | PF00017 | 0.480 |
LIG_SH3_2 | 150 | 155 | PF14604 | 0.370 |
LIG_SH3_2 | 306 | 311 | PF14604 | 0.661 |
LIG_SH3_3 | 112 | 118 | PF00018 | 0.362 |
LIG_SH3_3 | 147 | 153 | PF00018 | 0.375 |
LIG_SH3_3 | 300 | 306 | PF00018 | 0.616 |
LIG_TRAF2_1 | 282 | 285 | PF00917 | 0.584 |
LIG_TYR_ITIM | 110 | 115 | PF00017 | 0.397 |
LIG_TYR_ITIM | 77 | 82 | PF00017 | 0.370 |
LIG_UBA3_1 | 18 | 26 | PF00899 | 0.341 |
LIG_UBA3_1 | 349 | 353 | PF00899 | 0.534 |
MOD_CK1_1 | 163 | 169 | PF00069 | 0.313 |
MOD_CK1_1 | 33 | 39 | PF00069 | 0.348 |
MOD_CK2_1 | 128 | 134 | PF00069 | 0.279 |
MOD_CK2_1 | 268 | 274 | PF00069 | 0.620 |
MOD_CK2_1 | 279 | 285 | PF00069 | 0.770 |
MOD_CK2_1 | 341 | 347 | PF00069 | 0.535 |
MOD_GlcNHglycan | 270 | 273 | PF01048 | 0.714 |
MOD_GlcNHglycan | 279 | 284 | PF01048 | 0.729 |
MOD_GlcNHglycan | 329 | 332 | PF01048 | 0.293 |
MOD_GlcNHglycan | 35 | 38 | PF01048 | 0.233 |
MOD_GSK3_1 | 189 | 196 | PF00069 | 0.274 |
MOD_GSK3_1 | 254 | 261 | PF00069 | 0.606 |
MOD_GSK3_1 | 310 | 317 | PF00069 | 0.620 |
MOD_GSK3_1 | 33 | 40 | PF00069 | 0.312 |
MOD_N-GLC_1 | 143 | 148 | PF02516 | 0.299 |
MOD_NEK2_1 | 200 | 205 | PF00069 | 0.295 |
MOD_NEK2_1 | 290 | 295 | PF00069 | 0.635 |
MOD_NEK2_1 | 298 | 303 | PF00069 | 0.562 |
MOD_NEK2_2 | 235 | 240 | PF00069 | 0.259 |
MOD_PIKK_1 | 176 | 182 | PF00454 | 0.356 |
MOD_PK_1 | 160 | 166 | PF00069 | 0.279 |
MOD_PKA_2 | 176 | 182 | PF00069 | 0.427 |
MOD_PKA_2 | 310 | 316 | PF00069 | 0.652 |
MOD_PKA_2 | 359 | 365 | PF00069 | 0.472 |
MOD_PKA_2 | 64 | 70 | PF00069 | 0.360 |
MOD_PKA_2 | 87 | 93 | PF00069 | 0.346 |
MOD_Plk_1 | 332 | 338 | PF00069 | 0.475 |
MOD_Plk_4 | 193 | 199 | PF00069 | 0.345 |
MOD_Plk_4 | 42 | 48 | PF00069 | 0.324 |
MOD_ProDKin_1 | 242 | 248 | PF00069 | 0.415 |
MOD_ProDKin_1 | 291 | 297 | PF00069 | 0.596 |
MOD_SUMO_for_1 | 47 | 50 | PF00179 | 0.416 |
MOD_SUMO_rev_2 | 4 | 14 | PF00179 | 0.585 |
MOD_SUMO_rev_2 | 44 | 54 | PF00179 | 0.416 |
TRG_ENDOCYTIC_2 | 112 | 115 | PF00928 | 0.281 |
TRG_ENDOCYTIC_2 | 140 | 143 | PF00928 | 0.386 |
TRG_ENDOCYTIC_2 | 16 | 19 | PF00928 | 0.357 |
TRG_ENDOCYTIC_2 | 321 | 324 | PF00928 | 0.420 |
TRG_ENDOCYTIC_2 | 79 | 82 | PF00928 | 0.308 |
TRG_ENDOCYTIC_2 | 99 | 102 | PF00928 | 0.325 |
TRG_ER_diArg_1 | 159 | 162 | PF00400 | 0.315 |
TRG_Pf-PMV_PEXEL_1 | 207 | 211 | PF00026 | 0.384 |
TRG_Pf-PMV_PEXEL_1 | 237 | 242 | PF00026 | 0.252 |
TRG_Pf-PMV_PEXEL_1 | 322 | 326 | PF00026 | 0.441 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P6J9 | Leptomonas seymouri | 75% | 99% |
A0A0S4KH88 | Bodo saltans | 47% | 93% |
A0A1X0P910 | Trypanosomatidae | 51% | 97% |
A0A3Q8IBA5 | Leishmania donovani | 34% | 100% |
A0A3Q8IJ21 | Leishmania donovani | 95% | 100% |
A0A3R7KCX0 | Trypanosoma rangeli | 49% | 100% |
A0A422MZR8 | Trypanosoma rangeli | 34% | 100% |
A4H6L4 | Leishmania braziliensis | 35% | 100% |
A4HHT0 | Leishmania braziliensis | 83% | 100% |
A4HUZ7 | Leishmania infantum | 33% | 89% |
A4I4Z0 | Leishmania infantum | 95% | 100% |
C9ZKK9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 46% | 99% |
D0A7F2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 33% | 100% |
E9ALF1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
E9ANN2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 33% | 100% |
Q4QGZ1 | Leishmania major | 33% | 100% |
Q9Y365 | Homo sapiens | 32% | 100% |
V5BC62 | Trypanosoma cruzi | 50% | 100% |
V5DT41 | Trypanosoma cruzi | 35% | 100% |